Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velcade, Cyclophosphamide, and Revlimid in newly diagnosed multiple myeloma
NCT01729338Phase 2Terminated
- Sponsor
- Duke University
- Start
- Dec 2012
- Primary completion
- Dec 2015
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in multiple myeloma (MM), sponsored by Duke University. Started Dec 2012; status: terminated.
02
Drugs
bortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01729338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01729338.